Literature DB >> 12835091

Photodynamic therapy for nonmelanoma skin cancers. Current review and update.

Nathalie C Zeitouni1, Allan R Oseroff, Sherry Shieh.   

Abstract

Photodynamic therapy (PDT) is a therapeutic modality involving the use of a photosensitizing agent activated by light to destroy tumor cells. Over the past 25 years, PDT has been shown useful in the treatment of actinic keratoses and certain nonmelanoma skin cancers, such as Bowen's disease and basal cell carcinoma. We review the current data available for PDT with systemic photofrin and topical 5-aminolevulinic acid (ALA). PDT offers many advantages including its non-invasiveness and its ability to treat multiple lesions simultaneously and is, therefore, an interesting alternative for treating certain skin malignancies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835091     DOI: 10.1016/s0161-5890(03)00083-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

1.  Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression.

Authors:  Eugene Jeong; Ji Won Hong; Jung Ah Min; Dong Won Lee; Mi Yeung Sohn; Weon Ju Lee; Jun Young Lee; Young Min Park
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 2.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

3.  Painless versus conventional photodynamic therapy for treatment of actinic keratosis: Comparison of cell death and immune response in a murine model.

Authors:  Sanjay Anand; Anton Yasinchak; Mukul Govande; Sajina Shakya; Edward V Maytin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-02-28

4.  Cationic dendritic starch as a vehicle for photodynamic therapy and siRNA co-delivery.

Authors:  Sarah A Engelberth; Nadine Hempel; Magnus Bergkvist
Journal:  J Photochem Photobiol B       Date:  2017-02-20       Impact factor: 6.252

5.  Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.

Authors:  William J Cottrell; Anne D Paquette; Kenneth R Keymel; Thomas H Foster; Allan R Oseroff
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

6.  Glutathione S-transferase P1-1 expression modulates sensitivity of human kidney 293 cells to photodynamic therapy with hypericin.

Authors:  Michael J Dabrowski; Dean Maeda; John Zebala; Weiya Doug Lu; Sumit Mahajan; Terrance J Kavanagh; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2006-03-03       Impact factor: 4.013

7.  [Topical therapy of squamous cell carcinoma].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 8.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

9.  Interaction of cationic meso-porphyrins with liposomes, mitochondria and erythrocytes.

Authors:  Fabio M Engelmann; Ildemar Mayer; Dino S Gabrielli; Henrique E Toma; Alicia J Kowaltowski; Koiti Araki; Mauricio S Baptista
Journal:  J Bioenerg Biomembr       Date:  2007-04-14       Impact factor: 3.853

10.  Photodynamic therapy for multi-resistant cutaneous Langerhans cell histiocytosis.

Authors:  Valérie Failla; Odile Wauters; Marie Caucanas; Nazli Nikkels-Tassoudji; Arjen F Nikkels
Journal:  Rare Tumors       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.